DMD and limb-girdle muscular dystrophy: Similarly, patients affected with limb girdle muscular dystrophy (LGMD) who received AAV1 intramuscularly expressing an γ-sarcoglycan transgene, or DMD patients that received an AAV vector expressing the mini-dystrophin transgene, exhibited immunity toward vector antigens and demonstrated limited transgene expression [30].